Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Sci Total Environ ; 945: 173772, 2024 Oct 01.
Article in English | MEDLINE | ID: mdl-38871313

ABSTRACT

Nanoplastics (NPs) and polycyclic aromatic hydrocarbons (PAHs) are recognized as persistent organic pollutant (POPs) with demonstrated physiological toxicity. When present in aquatic environments, the two pollutants could combine with each other, resulting in cumulative toxicity to organisms. However, the combined impact of NPs and PAHs on microorganisms in seawater is not well understood. In this study, we conducted an exposure experiment to investigate the individual and synergistic effects of NPs and PAHs on the composition, biodiversity, co-occurrence networks of microbial communities in seawater. Exposure of individuals to PAHs led to a reduction in microbial community richness, but an increase in the relative abundance of species linked to PAHs degradation. These PAHs-degradation bacteria acting as keystone species, maintained a microbial network complexity similar to that of the control treatment. Exposure to individual NPs resulted in a reduction in the complexity of microbial networks. Furthermore, when PAHs and NPs were simultaneously present, the toxic effect of NPs hindered the presence of keystone species involved in PAHs degradation, subsequently limiting the degradation of PAHs by marine microorganisms, resulting in a decrease in community diversity and symbiotic network complexity. This situation potentially poses a heightened threat to the ecological stability of marine ecosystems. Our work strengthened the understanding of the combined impact of NPs and PAHs on microorganisms in seawater.


Subject(s)
Microbiota , Polycyclic Aromatic Hydrocarbons , Seawater , Water Pollutants, Chemical , Polycyclic Aromatic Hydrocarbons/toxicity , Polycyclic Aromatic Hydrocarbons/analysis , Seawater/chemistry , Seawater/microbiology , Water Pollutants, Chemical/toxicity , Microbiota/drug effects , Bacteria/drug effects , Water Microbiology , Microplastics/toxicity , Biodiversity , Environmental Monitoring
2.
Pediatr Res ; 82(5): 801-805, 2017 Nov.
Article in English | MEDLINE | ID: mdl-28700564

ABSTRACT

BackgroundThe biased immune reactions of the adenotonsillar tissues are not always reflected by the serum immunoglobulin E (IgE); thus, we hypothesize that the systemic atopic status may not be changed after the adenotonsillectomy (AT) in children.MethodsTwenty-five children with AT and 23 age-matched healthy children were enrolled into this study, and followed up for ~4 years. Nasal Symptoms Scores (NSS), Quality of Life Scores (QOLS), specific IgE (sIgE), cytokines, and inflammatory cell were documented in all the subjects before and after study.ResultsFourteen patients and three healthy controls had positive serum sIgE levels (>0.35 kU/l) at the study-start that was not changed by the study-end. Two patients and two sIgE-negative healthy controls showed the Dermatophagoidespteronyssinus sensitization at the study-end. NSS and QOLS showed significant improvement after the surgery in the sIgE-positive patients (P<0.05), whereas no significant changes were found in the sIgE-negative patients (P=1.00). In addition, the serum sIgE-negative patients showed significant increases in interleukin (IL)-4, IL-5, and IL-10 levels in the serum (P<0.001), although no significant differences were found post surgery (P=0.667, 0.408, and 0.714, respectively).ConclusionsOur study showed that AT did not affect the pediatric atopic status. The systemic atopy may be independent of the tonsillar and adenoid tissues in children.


Subject(s)
Adenoidectomy , Hypersensitivity/blood , Immunoglobulin E/blood , Tonsillectomy , Antigens, Dermatophagoides/administration & dosage , Antigens, Dermatophagoides/immunology , Arthropod Proteins/administration & dosage , Arthropod Proteins/immunology , Biomarkers/blood , Case-Control Studies , Child , Child, Preschool , Female , Humans , Hypersensitivity/diagnosis , Hypersensitivity/immunology , Hypersensitivity/prevention & control , Immunization , Inflammation/blood , Inflammation/immunology , Interleukin-10/blood , Interleukin-4/blood , Interleukin-5/blood , Male , Time Factors , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...